Money · Lobbying reports · 119th Congress
H.R. 1262
13 saved lobbying reports name H.R. 1262.
13 reports
Confirmed from the official recordSenate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.
Lobbying Disclosure Act reports, LDA.gov. This copy was read November 22, 2026 at 1:04 PM Eastern.
Reports that name this bill
The amount is what the report gives for the whole quarter: everything the registrant did for that client, all issues together. A linked name opens that organization’s page on this site.
| Registrant | Client | Amount for the whole quarter | Quarter | Filed | Report |
|---|---|---|---|---|---|
| NATIONWIDE CHILDREN'S HOSPITAL, INC. | NATIONWIDE CHILDREN'S HOSPITAL INC | $57,000.00reported as expenses | July to September 2026 | Open the report | |
| NATIONAL ASSOCIATION OF CHILDRENS HOSPITALS AND AFFILIATES | NATIONAL ASSOCIATION OF CHILDREN'S HOSPITALS (N.A.C.H.) | $1,520,000.00reported as expenses | July to September 2026 | Open the report | |
| DANA-FARBER CANCER INSTITUTE | DANA-FARBER CANCER INSTITUTE | $19,219.00reported as expenses | July to September 2026 | Open the report | |
| BIOGEN | BIOGEN | $880,000.00reported as expenses | July to September 2026 | Open the report | |
| MEHLMAN CONSULTING, INC. | THE CAMPAIGN FOR SUSTAINABLE RX PRICING | $90,000.00reported as income | July to September 2026 | Open the report | |
| ACADIA PHARMACEUTICALS | ACADIA PHARMACEUTICALS | $440,000.00reported as expenses | July to September 2026 | Open the report | |
| TRAVERE THERAPEUTICS | TRAVERE THERAPEUTICS | $100,000.00reported as expenses | July to September 2026 | Open the report | |
| LMH STRATEGIC SOLUTIONS | PTC THERAPEUTICS, INC. | $50,000.00reported as income | July to September 2026 | Open the report | |
| LMH STRATEGIC SOLUTIONS | IONIS PHARMACEUTICALS, INC. | $30,000.00reported as income | July to September 2026 | Open the report | |
| SMITHBUCKLIN CORPORATION | ASTCT | $70,000.00reported as income | July to September 2026 | Open the report | |
| IONIS PHARMACEUTICALS, INC. | IONIS PHARMACEUTICALS, INC. | $150,000.00reported as expenses | July to September 2026 | Open the report | |
| BRACEWELL LLP | NATIONAL BRAIN TUMOR SOCIETY | $20,000.00reported as income | July to September 2026 | Open the report | |
| HEALTHCARE INSTITUTE OF NEW JERSEY | HEALTHCARE INSTITUTE OF NEW JERSEY | $49,416.00reported as expenses | July to September 2026 | Open the report |